Glycosphingolipid synthesis inhibition limits osteoclast activation and myeloma bone disease. (2015)
Attributed to:
Core Support for Collaborative Research in Glycobiology
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1172/jci59987
PubMed Identifier: 25915583
Publication URI: http://europepmc.org/abstract/MED/25915583
Type: Journal Article/Review
Volume: 125
Parent Publication: The Journal of clinical investigation
Issue: 6
ISSN: 0021-9738